ZWG-18586-53252
1 vaccination
1 coded response
3 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 664 / KS
- Registered
- 2021-01-26
- Relationship
- Self
Timeline
-
2021-01-26
Registered in v-safe
-
2021-01-26
Dose 1 — Pfizer-BioNTech
- 2021-01-26
-
2021-01-27
Survey response — days 1–6 daily, dose 1MedDRA: Thirst — Feeling: Fair · Site: Pain · Chills, Headache, Rash, not including the immediate area around the injection site · Be unable to workFree text: ThirstMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-27
-
2021-01-28
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Chills, HeadacheAdult check-in
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-26 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-27 | priority 2/3 |
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Thirst
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Thirst | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release